Neuroretinal damage associated with pituitary macroadenoma: endocrine and radiological predictors and correlation with optical coherence tomography-derived biomarkers

• by Diego Fernandez-Velasco, Elena Garcia-Martin, Belen Santamaria, María Jesús Rodrigo

• June 26, 2026

SGLT2 Inhibitors Tied to Lower Kidney Cancer Risk

A Korean cohort study found fewer kidney cancer cases among patients with type 2 diabetes who initiated sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors.

• by Andrea Surnit

• June 9, 2026

• 5 min

Selpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: A network meta-analysis of RET-targeted therapies

• by Jiazhong Wang, Gang Cao, Yang Liu, Hao Qiao, Qiao He, Bo Zheng

• June 22, 2026

Association between tumor genomic mutations and the risk of PD-1 inhibitor-induced hypophysitis: a retrospective cohort study

• by Yuanyuan Zheng, Yizhen Chen, Wei Lin, Le Min

• June 8, 2026